Tanoto Foundation Medical Research Fund

Tanoto Foundation supports medical research with the aim of improving population health in Singapore and beyond. We believe that the goal of improving quality of healthcare and health standards can be achieved through partnerships with leading healthcare and research institutions in Singapore.

Through the Tanoto Foundation Medical Research Fund (MRF), the foundation aims to support research excellence and collaborative efforts to generate new knowledge and innovations that will help address prevalent diseases in Singapore and the wider region, such as diabetes, cardiology, oncology, infectious diseases and maternal and child health. In position as the first private philanthropic foundation to launch such a fund, Tanoto Foundation seeks to foster a culture of sustainable giving that amplifies the long-term impact of philanthropic-funded research.

The MRF’s main objectives are to support effective research (new discoveries), catalyse additional funding and cultivate local research talent in Singapore. Ultimately, the research outcomes should be made accessible and beneficial for the public good.

2024 Application Cycle

FUNDING

The MRF will grant up to S$5 million each cycle

EVALUATION CRITERIA

Applications will be evaluated in two stages by an Advisory Panel, which comprises esteemed scientists and clinicians, and subsequently recommended to Tanoto Foundation Board for approval.

First Stage: Letter of Intent (LOI) evaluation

LOIs will be evaluated based on the significance and relevance of the research to MRF’s main objectives which are to support effective research (new discoveries), catalyse additional funding and cultivate local research talent in Singapore. Ultimately, the research outcomes should be made accessible and beneficial for the public good.

Second Stage: Full Proposal evaluation

Full proposals will be evaluated based on four general criteria:

Potential for impact – potential for translation and innovation to advance clinical practices and technical capabilities to improve health outcomes in Singapore.
Robustness of approach – relevance and robustness of strategy, methodology and analyses to accomplish project aims and impact outcomes.
Profile and track record of study team – the excellence and accomplishments of the study team and potential/plan for talent development, PI and Co-PI involvements and contributions to the study.
Strength of collaboration – the collaborative effort of multi-disciplinary teams, ideally involving cross collaboration across Singapore healthcare clusters.

TIMELINE

Call for LOI: 09 September 2024
LOI deadline: 18 October 2024
Invite for Full Proposals: December 2024
Full Proposal deadline: January 2025
Announcement of results: April to May 2025

MORE INFORMATION
Click HERE to download the MRF guidelines and submission instructions.

Tanoto Foundation Medical Research Fund

Subscribe to our newsletter

2024 Application Cycle

Social Feed